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1. ABSTRACT 
 
Introduction:  
While the benefits of neurointerventional procedures outweigh the risks, there is potential 
for high radiation exposure. Increasing regulatory requirements require dose monitoring 
of patients and staff, and justification of aberrant exposures. This paper uses radiation 
dose tracking software to assess factors which influence neuroradiology radiation doses.  
 
Methods:  
Consecutive neurointerventional procedures within a one-year period from November 
2014 to November 2015 were retrospectively studied. Dose area product (DAP) was 
collected using dose-tracking software and clinical data was obtained from a 
prospectively generated patient treatment database. Data analysis was performed on 
SPSS software. 
 
Results: Two hundred and sixty-four neurointerventional procedures met the selection 
criteria. Median dose area product (DAP) for aneurysm procedures was 104.9 Gy-cm2, 
259.4 Gy-cm2 for arteriovenous malformation embolization procedures, 87 Gy-cm2 for 
stroke thrombolysis, and 73.7 Gy-cm2 for 4-vessel angiography. One hundred and nine 
aneurysm coiling procedures were further studied. Six significant variables were assessed 
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using stepwise regression analysis to determine effect on DAP. Aneurysm location 
(anterior circulation vs. posterior circulation) had the single biggest effect (p = 0.004). 
 
Conclusion: Neurointerventional procedures produce variable radiation exposures. 
Anterior and posterior aneurysm coiling procedures should have separate DRLs.    
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Introduction 
 
Neurointervention is an increasingly common method for treating neurological diseases 
[1]. Continued technological developments are extending the range and complexity of 
conditions which neurointerventional radiologists can treat. While there are considerable 
benefits to having a neurointerventional procedure performed over surgery, risks remain, 
one of which is the exposure of patients and staff to ionising radiation during the 
procedure.  
 
Deterministic complications such as skin erythema occur at a threshold dose of 2 Grays 
(Gy), whereas 7 Gy can cause permanent hair loss [2,3]. Cataract formation is a notable 
risk as the eyes are exposed to radiation throughout the procedure[2,4]. Staff eye doses are 
also of concern. The International Commission on Radiological Protection (ICRP) has 
recently recommended a reduction threshold dose for cataract induction from 2 Gy to 0.5 
Gy be instituted. As a result, the dose limit for eye exposure among staff has been 
reduced from 150mSv to 20mSv over a five year period)[5].  
 
The Euratom 2013/59 directive has also made these recommendations meaning that these 
limits will become a regulatory requirement by February 2018 [6]. The International 
Radiation Protection Agency has recognised that these changes will have implications for 
radiation dose monitoring and anticipate that interventional radiology and cardiology are 
of greatest likelihood to encounter the impact of these changes [7]. There is concern that 
based on current work practices that there is potential to exceed these limits [8]. Therefore 
new regulations could have significant implications for the number and complexity of 
procedures which an interventionalist can perform, and in turn resource implications for 
tertiary care health institutions.  
 
Requirements for recording radiation dose, calculation and review of diagnostic reference 
levels (DRLs) in addition to keeping radiation doses as low as reasonable achievable also 
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have resource implications. There are challenges with current methods of collecting dose 
related data. In CT it has been noted that many studies are incorrectly registered due to 
non-uniform procedure coding which results in missing procedural data [9].  
 
The need for more reliable methods of standardized data collection has been addressed 
through the development of dose tracking software tools [10-13] Furthermore it has been 
shown that 32% of the performed procedures have incomplete radiation dose estimates or 
fluoroscopy times recorded when they should have been manually documented at the 
time of examination [12]. In addition, several methods can be used to measure radiation 
dose which can impede the optimisation process when doses in two intervention rooms in 
the same institution cannot be directly compared [12].  
 
Dose tracking software automatically collects procedure-related radiation dose data 
obviating human input error and in a more efficient manner. Given that these data are 
now readily available the next challenge for healthcare providers is to use the data to 
inform decision making processes regarding patient consent, radiation protection 
standardization and optimisation. The purpose of this study was to correlate radiation 
dose data gathered using dose tracking software with clinical parameters pertaining to 
neurointerventional procedures and to determine factors associated with increased 
radiation exposures. These data were then used to assess how DRLs could be best 
calculated. 
 
METHODS 
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Board ethical approval was granted for this retrospective descriptive cohort study 
performed at a single institution. All neuroradiology procedures were performed in a 
tertiary referral center by one or both of the two staff neuroradiologists. Aneurysm 
coiling was performed under general anaesthesia. Neurointerventional procedures 
conducted during the period of November 2014 and November 2015 and included 
patients who underwent one of four neurointerventional procedures. These were: (1) four 
vessel angiogram, (2), aneurysm coiling, (3) arteriovenous malformation embolization, 
and (4) stroke thrombolysis. An expanded cohort of aneurysm coiling procedures patients 
treated between November 2014 and September 2016 were included following power 
analysis to allow accurate subgroup analysis.  
 
We measured radiation dose using Dose Area Product (also known as Kerma Area 
Product), which is expressed as mGy.cm2. Dose data was collected using a picture 
archiving and communications system (PACS) (Impax 6.5.3; Afga healthcare, Morstel, 
Belgium), and the dose tracking software (DoseWatch, General Electric Healthcare, 
Waukesha, WI, USA). Data were entered onto a Microsoft Office Excel 2010 spreadsheet 
(Microsoft Corporation, CA, USA). Patient sex, patient age, procedure type, number of 
exposures, screening time, devices used and time of day were recorded for all procedures. 
For aneurysm coiling procedures, the following additional parameters: site, size, number 
of coils used, number and shape of aneurysms. Clinical and procedural data on aneurysm 
neurovascular treatments was taken from a prospectively gathered data file maintained by 
a neuroradiologist.  
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Statistical analysis was performed with Statistical Package for Social Scientists (SPSS) 
software version 23 (IBM, Armonk, NY) and Prism 7 (GraphPad, San Diego, California).  
Descriptive statistical tests were used to show the median, mean, maximum and 
minimum radiation dose for each of the four procedures over a one-year period. Tests for 
normality of distribution were performed using the D’Agostino and Pearson normality 
test. Additional descriptive analysis was used to determine average age for each 
procedure and relationship between procedure and sex.  
 
We performed additional analysis on the 4-vessel angiogram and aneurysm coiling data. 
Wilcoxon matched pairs signed rank test was used to compare anterior verses posterior 
aneurysm treatment DAPs. Aneurysm-related variables were analysed using two different 
statistical tests depending on the number of groups per variable. The Mann-Whitney U 
test was used for variables with two groups. The Kruskel-Wallis test was used for 
variables with more than two groups. Variables were found to be significant if the p value 
was less than 0.05. Significant variables were then analysed using stepwise linear 
regression to determine which variable had the single biggest effect on radiation dose 
(DAP). 
 
RESULTS 
Two hundred and sixty-four consecutive patients who underwent neurointerventional 
procedures were eligible for inclusion. Of the 264 procedures, 189 four-vessel 
 8 
angiograms, 59 aneurysm coilings, 10 stroke thrombolysis, and 6 arteriovenous 
malformation embolization procedures were performed. An additional cohort of 60 
consecutive patients who underwent aneurysm coiling procedures was added to the 
aneurysm group to enable subgroup analysis, forming a cohort of 109 patients in total 
(table 1).  
 
Overall, 61% of the patients were female and 39% were male. The age of participants 
ranged 15-82 with an average age of 52.5 years for male patients and 53.9 years for 
female patients. Procedures distinguished by sex differed substantially. The number of 
aneurysm coiling procedures performed on women was almost double (1.94x) the 
number performed on men. In contrast to this, AVM embolization and stroke 
thrombolysis were performed on men at an increased rate of 5x and 2.3x respectively, 
compared withnwomen. Over all, women were more likely to undergo both diagnostic 
and therapeutic procedures. 
 
 
Radiation Dose 
The median DAP for four-vessel angiography was 73,726 mGy.cm2 (3rd quartile: 96,326 
mGy.cm2, interquartile range: 49,011 mGy.cm2). The median radiation DAP for 
aneurysm coiling was 100,431 mGy.cm2 (3rd quartile: 122,945 mGy.cm2, interquartile 
range: 49,336). The median radiation DAP for arteriovenous malformation embolization 
was 259,403 mGy.cm2 (3rd quartile: 310118 mGy.cm2, interquartile range: 204,591 
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mGy.cm2). The median radiation DAP for stroke thrombolysis was 87,004 mGy.cm2 (3rd 
quartile: 172,261, interquartile range: 125,017 mGy.cm2 (Table 2). 
 
 
Figure 1 demonstrates the range of radiation doses for each procedure type. A number of 
outliers occurred in the aneurysm coiling and four-vessel angiogram groups. These cases 
were reviewed to determine causes for the increased doses. Three out of the four, four-
vessel angiogram outlier cases had an arteriovenous malformation. Two of the six 
aneurysm coiling procedure outliers were for posterior circulation aneurysm procedures, 
one of which had an intraoperative complication. Three of the remaining cases had 
anterior circulation aneurysms that developed complications during the procedure. Nine 
aneurysm-related variables were found to have a significant effect on DAP (Table 3). The 
first six variables listed in table 3 were chosen for further analysis (the three other 
variables involved treatment of a second aneurysm on the same procedure date). Stepwise 
regression was performed on these variables to determine which variable had the single 
biggest effect on radiation dose.  Aneurysm location was found to have the single greatest 
affect on radiation dose (p-value = .004) (Tables 4 and 5). 
 
Given the affect that aneurysm location had on radiation dose separate DRLs for the 
anterior and posterior aneurysm coiling procedures were calculated. The median DAP 
and 3rd quartiles for anterior circulation aneurysms were 97,824 mGy.cm2 and 119,290 
mGy.cm2, respectively, while posterior circulation aneurysm treatment resulted in a median 
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DAP of 127,160 mGy.cm2 and a 3rd quartile DAP of 151,475 mGy.cm2. These differences 
were statistically significant (p = 0.0005) (Fig. 3).  
 
Discussion 
The calculation and monitoring of DRLs for high dose medical examinations such as 
neurointerventional procedures is an important component of the Eurotaom BSS 
directive i . The 75th percentile (third quartile) of the spread of the median doses is 
considered an appropriate DRL estimate. This has been used in assessment of 
neuroradiology procedures to date [14] [15]. Using reference levels in the 75th percentile 
accommodates the potentially skewed distribution of radiation dose but the creation of 
useful DRLs requires the inclusion of sufficient data. This can be a challenge for certain 
neurointerventional procedures, which have a propensity for complexity and high 
probability of case outliers.  
 
In the present paper dose tracking software provided a resource efficient means of 
gathering median DAP for each procedure. The following DRL (3rd quartile values) 
values were calculated: 96,326 mGy.cm2 for 4-vessel angiogram procedures; and 122,945 
mGy.cm2 for aneurysm coiling procedures. The following DRLs were also calculated: 
172,261 mGy.cm2 for stroke intervention procedures; and 310,118 mGy.cm2 for AVM 
embolization, however, the number of procedures performed in these cohorts were small 
and additional numbers of patients would be added for accuracy. The use of the 75th 
centile for DRL calculation was confirmed as exclusion of dose outliers in the aneurysm 
coiling group (due to intraoperative complications) slightly reduced the 3rd quartile to 
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119,909 mGy.cm2 (Fig. 2), however, using a Wilcoxon matched-pairs signed rank test, 
this difference was deemed to be non-significant (P value = 0.97).  
 
The gathering of DAP data not only provides a means of meeting regulatory requirements 
but can also be used to inform clinicians and radiographers as to expected doses for 
neurointerventional procedures and to alert them to individual cases that may have higher 
than expected doses. In our department the dose tracking software has been set to create 
an alert when the dose exceeds twice the median dose for a particular radiological 
investigation or procedure. Using the data from dose tracking software, the alert level for 
4-vessel angiography was 147,452 mGy.cm2 and 11 patients out of 189 patients reached 
this threshold. For aneurysm coiling procedures, 200,862 mGy.cm2 represented twice the 
median dose and generated 5 alerts from 109 cases. The issuing of an alert lead to an 
assessment of case and required justification of the increased dose. Multiple outliers in 
two procedure types provided cause for review (see Figure 1).  Three of the four four-
vessel angiogram outliers were performed on patients with an arteriovenous 
malformation. In these cases increased dose was justified due to the complexity of the 
vascular deformity, requiring additional views and acquisitions to better visualise feeding 
any draining vessels and assess for intra-lesional aneurysms [11]. 
 
Aneurysm coiling procedure variables 
An assessment of procedural factors contributing to increased radiation dose during 
aneurysm coiling procedures was performed.  Two of the six outliers had posterior 
circulation aneurysms, where as complications including coil and flow diverter device 
 12 
herniation, thrombus formation, and vasospasm occurred in the remaining four procedure 
outliers. The occurrence of a complication resulted in increased patient radiation dose as 
additional imaging was required to treat the complication. 
 
Complications were not, however, the main determinant of radiation dose. Regression 
analysis demonstrated that the location of a patient’s aneurysm was the single biggest 
influence on radiation dose (p = 0.004). Aneurysms in the posterior cerebral circulation 
are more difficult to treat and this entails a higher complication risk compared with 
anterior circulation aneurysms [16]. Posterior circulation aneurysms also have a higher risk 
of rupture [17]. The risk of death from rupture of a posterior circulation aneurysm is much 
higher than rupture of an anterior circulation aneurysm [18]. The use of a Pipeline 
embolization device (ev3-Covidien, Irvine, California, USA) and use of a stent for 
aneurysm coiling procedures both increased radiation dose [19].  The use of these devices 
was associated with increased procedure times and potentially higher complication risk 
due to unfavourable anatomy. National DRLs exist in many countries for aneurysm 
coiling procedures. The results of the present paper highlight the need to monitor doses 
for anterior and posterior circulation aneurysm coiling procedures separately and 
calculate DRLs for each in turn.  
 
 
The DAP levels for cerebral angiogram (n=189) documented in the present paper are 
lower than other published studies (median 73,726 mGy.cm2, mean 76,024 mGy.cm2). 
For example, Aroua et al. [14] calculated a mean DAP for cerebral angiography of 121,000 
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mGy.cm2, Alexander et al. [12] calculated a mean DAP of 102,400 mGy.cm2, and Sanchez 
et al. [14] calculated a median DAP of 73,000 mGy.cm2. There are many potential 
contributors to this including patient selection, operator experience, and equipment dose 
efficiency. This phenomenon highlights the need for calculation and monitoring of local 
DRLs within one’s own institution. The introduction of new staff and equipment will 
likely require a reassessment of dose related data to maintain accuracy. Additionally 
DRLs are intended for reference purposes and it is important to continue to strive towards 
improved radiation protection practices in order to keep doses as low as reasonable 
practicable. 
 
The present paper has not included sufficient arteriovenous malformation embolizations 
and intraarterial thrombolysis cases to facilitate robust analysis. This is a common 
challenge since such procedures compose a small proportion of neuroradiology 
procedures [21, 22]. This challenge also makes it more difficult to identify dose outliers. 
The use of DAP as a surrogate for patient received dose does introduce an inherent 
inaccuracy into the data as received dose varies depending on multiple factors such as 
position and distance of the tube relative to the patient as well as the length of time spent 
in a particular tube position [20]. While it is possible for dose monitoring software to 
calculate skin dose based on patient location and tube position, these are not readily 
available and DAP will likely remain the basis for the calculation of DRLs [23]. 
 
In conclusion, innovations in interventional radiology have increased treatment 
capabilities, which have potential to impact radiation doses incurred by patients and staff. 
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Compliance with regulatory requirements for monitoring of radiation exposures and 
justification of dose outliers requires a coordinated approach for gathering dose and 
clinical data. Dose tracking software provides an efficient means of gathering dose 
related data. The present paper confirms that the 75th centile provides a reasonable DRL 
value which is not affected by dose outliers. Results also indicate that aneurysm location 
has the greatest impact on dose related to coiling procedures and that anterior and 
posterior coiling procedures should have separate DRLs.  
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     PROCEDURE 
4-Vessel 
Angiogram 
Aneurysm 
Coiling 
AVM 
Embolisation 
Stroke 
Thrombolysis 
Total 
189 
109 6 10 314 
Table 1. Summary of procedures for study. 
 
 
 
Dose Area Product (DAP) for neurointerventional procedures 
Procedure Measure  Statistic 
4-vessel angiogram Mean  76,024 
 Median  73,726 
 75% percentile  96,326 
 Minimum  9,424 
 Maximum  244,134 
Aneurysm coiling Mean  108,021 
 Median  100,431 
 75% percentile  122,945 
 Minimum  42,807 
 Maximum  365,841 
AVM embolization Mean  223,852 
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 Median  259,403 
 75% percentile  310,118 
 Minimum  74,236 
 Maximum  330,935 
Stroke thrombolysis Mean  107368 
 Median  87004 
 75% percentile  172,261 
 Minimum  37,028 
 Maximum  191,422 
Table 2. Summary of radiation Dose Area Product measurement for interventional 
procedures. (All values written as mGy.cm2) 
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Table 3. Variables affecting DAP for aneurysm coiling procedures: A1 Pipeline = use of 
pipeline device during procedure for aneurysm 1. A1 Stent = use of a stent during 
procedure for aneurysm 1. A1 Complications = complications occurred during procedure 
for aneurysm 1. Aneurysm Location = whether aneurysm was present in the posterior 
cerebral circulation. A1 Body Remnant = Raymond-Roy 3. Aneurysm2 = presence of a 
second aneurysm. Aneurysm2 Procedure = procedure performed on second aneurysm. 
Aneurysm2 Coiling = coiling performed on second aneurysm. A2 Remodelling = use of 
balloon to stabilize coils during second aneurysm procedure 
 
 
Variable 
 
Significance 
A1 Pipeline 
A1 Stent 
A1 Complications 
Aneurysm Location 
A1 Body Remnant 
Aneurysm2 
Aneurysm2 Procedure 
A2 Coiling 
A2 Remodelling 
.037 
.019 
.000 
.008 
.035 
.004 
.020 
.044 
.013 
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Model 
 
 
Beta In 
 
 
t 
 
 
Sig. 
 
Partial 
Correlation 
 
Collinearity 
 
Tolerance 
1    A1 Pipeline 
      A1 Stent 
      A1 Complications 
      A1 Body Remnant  
      Aneurysm2 
.051b 
.002b 
.099b 
.037b 
.031b 
.529 
.023 
1.047 
.384 
.322 
.598 
.982 
.298 
.702 
.748 
.053 
.002 
.104 
.038 
.032 
.938 
.979 
.999 
.993 
.996 
Table 4. Excluded variables on dose following stepwise regression analysis 
 
 
Table 5. Aneurysm Location effect on DAP 
 
 
 
 
Model 
 
Sum of 
Squares 
 
df 
 
Mean Square 
 
F 
 
Sig. 
1          Regression              Residual Total 
3.596E+11 4.105E+12 4.465E+12 
1 102 103 
3.596E+11 40248883591 8.934 .004b 
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Figure 1: Box and whiskers (Tukey) graph showing median DAP and outliers for the 
neurovascular procedures analysed 
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Figure 2: Box and whiskers (Tukey) graph showing median DAP and outliers for all 
treated aneurysms (including cases with complications) verses DAP for treated aneurysm 
cases excluding those with intra-operative complications. (p = 0.9798) 
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Figure 3: Box and whiskers (Tukey) graph showing median DAP and outliers for treated 
anterior aneurysms verses posterior aneurysms (p = 0.0005)                                                         i 2. Council of the European Union. (2013). Council Directive 2013/59/Euratom laying down basic 
safety standards for protection against the dangers arising from exposure to ionising radiation, 
and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom and 
2003/122/Euratom. Official Journal L-13 of 17.01.2014.  
